ISRG vs TSLA: Which Is the Better Buy?
Side-by-side comparison of Intuitive Surgical, Inc. and Tesla, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-22.
Intuitive Surgical, Inc. · Healthcare
$451.29
+45.0% upside to fair value
Grade B
High Quality
VS
Tesla, Inc. · Consumer Cyclical
$387.51
-45.0% upside to fair value
Grade D
QuantHub Verdict
ISRG has more upside to fair value
(+45.0%).
ISRG trades at a lower forward P/E
(53.8x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ISRG |
TSLA |
| Current Price |
$451.29 |
$387.51 |
| Fair Value Estimate |
$654.37 |
$213.13 |
| Upside to Fair Value |
+45.0%
|
-45.0%
|
| Market Cap |
$160.3B |
$1,454.1B |
| Forward P/E |
53.8x
|
330.0x
|
| EV / EBITDA |
40.5x
|
122.9x
|
| Price / Sales |
15.2x
|
15.3x
|
| Price / FCF |
64.3x
|
233.8x
|
| Revenue Growth YoY |
+23.0%
|
-3.1%
|
| Gross Margin |
66.3%
|
18.0%
|
| Operating Margin |
30.5%
|
4.6%
|
| Return on Equity |
17.0%
|
4.8%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
1.55%
|
0.43%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Intuitive Surgical, Inc. is a leading healthcare company specializing in robotic-assisted surgery through its flagship da Vinci system, which has established a durable competitive moat with approximately 10,000 systems installed globally and nearly 17 million procedures performed by the end of 2024. The company benefits from a high-quality business model characterized by 85% recurring revenue, st…
Tesla, Inc. is a leading global manufacturer of electric vehicles, energy storage, and solar products, led by CEO Elon Musk since 2008. The company has a mixed business quality profile with a strong brand and innovation leadership but faces significant challenges including declining automotive revenue, which fell nearly 10% year-over-year in 2025, and a 3.1% revenue decline in the most recent qua…
Accumulation Zones
| Metric |
ISRG |
TSLA |
| Zone Low |
$490.78 |
$159.85 |
| Zone High |
$556.21 |
$181.16 |
| In Buy Zone? |
Yes
|
No
|